<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39430762</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Systemic increase in IL-26 is associated with severe COVID-19 and comorbid obstructive lung disease.</ArticleTitle><Pagination><StartPage>1434186</StartPage><MedlinePgn>1434186</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1434186</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1434186</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">IL-26 is a key mediator of pulmonary host defense given its abundant expression in human airways and its established antibacterial properties. Moreover, recent studies indicate that IL-26 can also inhibit viral replication. Along these lines, we have previously reported an increase in the plasma concentration of IL-26 among patients with acute COVID-19 that is linked to harmful hyperinflammation. Nevertheless, it is still unclear whether this systemic increase in IL-26 relates to disease severity, sex, comorbidities, viral load, or the innate immune response in acute COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">IL-26 was quantified using ELISA in plasma samples from a large cohort of well-characterized patients with acute COVID-19 (n=178) and healthy controls (n=30). The plasma concentrations of SARS-CoV-2 nucleocapsid and spike protein, as well as those of IFN-α2a, IFN-β, and IFN-γ, were determined using electrochemiluminescence immunoassay. The concentration of double-stranded DNA was determined using fluorometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The plasma concentration of IL-26 was increased in patients with severe/critical COVID-19, particularly among males and patients with comorbid obstructive lung disease. Moreover, the concentration of IL-26 displayed positive correlations with length of hospital stay, as well as with systemic markers of viral load, antiviral immunity, and extracellular DNA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Systemic IL-26 is involved in severe COVID-19, especially in males and patients with comorbid obstructive lung disease. These findings argue that systemic IL-26 has pathogenic and antiviral relevance, as well as biomarker potential.</AbstractText><CopyrightInformation>Copyright © 2024 Cardenas, Robertson, Misaghian, Brown, Wang, Stengelin, Sigal, Wohlstadter, Gisslén and Lindén.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cardenas</LastName><ForeName>Eduardo I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Division of Lung and Airway Research, Institute of Environmental Medicine, and the Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Ear, Nose and Throat Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Josefina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misaghian</LastName><ForeName>Salvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Jermaine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mingyue</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stengelin</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigal</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wohlstadter</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Meso Scale Diagnostics, LLC., Rockville, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gisslén</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Agency of Sweden, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindén</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Lung and Airway Research, Institute of Environmental Medicine, and the Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Karolinska Severe COPD Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C406767">IL26 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="Y">Interleukins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COPD</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IL-26</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">asthma</Keyword></KeywordList><CoiStatement>Authors SM, JB, MW, MS, GS, and JW are employed by Meso Scale Diagnostics, LLC., Rockville, MD, USA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39430762</ArticleId><ArticleId IdType="pmc">PMC11486738</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1434186</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cardenas EI, Che KF, Konradsen JR, Bao A, Linden A. Il-26 in asthma and copd. Expert Rev Respir Med. (2022) 16:293–301. doi: 10.1080/17476348.2022.2045197</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2022.2045197</ArticleId><ArticleId IdType="pubmed">35188435</ArticleId></ArticleIdList></Reference><Reference><Citation>Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, et al. . T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26. Nat Immunol. (2015) 16:970–9. doi: 10.1038/ni.3211</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3211</ArticleId><ArticleId IdType="pmc">PMC4776746</ArticleId><ArticleId IdType="pubmed">26168081</ArticleId></ArticleIdList></Reference><Reference><Citation>Che KF, Paulsson M, Piersiala K, Sax J, Mboob I, Rahman M, et al. . Complex involvement of interleukin-26 in bacterial lung infection. Front Immunol. (2021) 12:761317. doi: 10.3389/fimmu.2021.761317</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.761317</ArticleId><ArticleId IdType="pmc">PMC8581676</ArticleId><ArticleId IdType="pubmed">34777376</ArticleId></ArticleIdList></Reference><Reference><Citation>Che KF, Tengvall S, Levanen B, Silverpil E, Smith ME, Awad M, et al. . Interleukin-26 in antibacterial host defense of human lungs. Effects on neutrophil mobilization. Am J Respir Crit Care Med. (2014) 190:1022–31. doi: 10.1164/rccm.201404-0689OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201404-0689OC</ArticleId><ArticleId IdType="pubmed">25291379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao A, Che KF, Bozinovski S, Ji J, Gregory JA, Kumlien Georen S, et al. . Recombinant human il-26 facilitates the innate immune response to endotoxin in the bronchoalveolar space of mice in vivo. PloS One. (2017) 12:e0188909. doi: 10.1371/journal.pone.0188909</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188909</ArticleId><ArticleId IdType="pmc">PMC5716532</ArticleId><ArticleId IdType="pubmed">29206862</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulsson M, Cardenas EI, Che KF, Brundin B, Smith M, Qvarfordt I, et al. . Tlr4-mediated release of heparin-binding protein in human airways: A co-stimulatory role for il-26. Front Immunol. (2023) 14:1178135. doi: 10.3389/fimmu.2023.1178135</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1178135</ArticleId><ArticleId IdType="pmc">PMC10206387</ArticleId><ArticleId IdType="pubmed">37234157</ArticleId></ArticleIdList></Reference><Reference><Citation>Knappe A, Hor S, Wittmann S, Fickenscher H. Induction of a novel cellular homolog of interleukin-10, ak155, by transformation of T lymphocytes with herpesvirus saimiri. J Virol. (2000) 74:3881–7. doi: 10.1128/jvi.74.8.3881-3887.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.8.3881-3887.2000</ArticleId><ArticleId IdType="pmc">PMC111897</ArticleId><ArticleId IdType="pubmed">10729163</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins PL, Henderson MA, Aune TM. Lineage-specific adjacent ifng and il26 genes share a common distal enhancer element. Genes Immun. (2012) 13:481–8. doi: 10.1038/gene.2012.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2012.22</ArticleId><ArticleId IdType="pmc">PMC4180225</ArticleId><ArticleId IdType="pubmed">22622197</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. . Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. (2009) 119:3573–85. doi: 10.1172/JCI40202</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI40202</ArticleId><ArticleId IdType="pmc">PMC2786807</ArticleId><ArticleId IdType="pubmed">19920355</ArticleId></ArticleIdList></Reference><Reference><Citation>Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, et al. . Il-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. (2011) 208:1127–33. doi: 10.1084/jem.20101712</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20101712</ArticleId><ArticleId IdType="pmc">PMC3173242</ArticleId><ArticleId IdType="pubmed">21576383</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaumont E, Larochette V, Preisser L, Miot C, Pignon P, Blanchard S, et al. . Il-26 inhibits hepatitis C virus replication in hepatocytes. J Hepatol. (2022) 76:822–31. doi: 10.1016/j.jhep.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.12.011</ArticleId><ArticleId IdType="pubmed">34952035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P, et al. . Tlr2 senses the sars-cov-2 envelope protein to produce inflammatory cytokines. Nat Immunol. (2021) 22:829–38. doi: 10.1038/s41590-021-00937-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, et al. . Publisher correction: sars-cov-2 spike protein interacts with and activates tlr4. Cell Res. (2021) 31:825. doi: 10.1038/s41422-021-00501-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00501-0</ArticleId><ArticleId IdType="pmc">PMC8077189</ArticleId><ArticleId IdType="pubmed">33907310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, et al. . Tlr3 and tlr7 rna sensor activation during sars-cov-2 infection. Microorganisms. (2021) 9:1–14. doi: 10.3390/microorganisms9091820</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091820</ArticleId><ArticleId IdType="pmc">PMC8465566</ArticleId><ArticleId IdType="pubmed">34576716</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi V, Nguyen HO, Sozio F, Schioppa T, Gaudenzi C, Laffranchi M, et al. . Sars-cov-2-associated ssrnas activate inflammation and immunity via tlr7/8. JCI Insight. (2021) 6:1–15. doi: 10.1172/jci.insight.150542</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150542</ArticleId><ArticleId IdType="pmc">PMC8492321</ArticleId><ArticleId IdType="pubmed">34375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Che KF, Kaarteenaho R, Lappi-Blanco E, Levanen B, Sun J, Wheelock A, et al. . Interleukin-26 production in human primary bronchial epithelial cells in response to viral stimulation: modulation by th17 cytokines. Mol Med. (2017) 23:247–57. doi: 10.2119/molmed.2016.00064</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2016.00064</ArticleId><ArticleId IdType="pmc">PMC5653736</ArticleId><ArticleId IdType="pubmed">28853490</ArticleId></ArticleIdList></Reference><Reference><Citation>Che KF, Sun J, Linden A. Pharmacological modulation of endotoxin-induced release of il-26 in human primary lung fibroblasts. Front Pharmacol. (2019) 10:956. doi: 10.3389/fphar.2019.00956</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00956</ArticleId><ArticleId IdType="pmc">PMC6729122</ArticleId><ArticleId IdType="pubmed">31543817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas EI, Ekstedt S, Piersiala K, Petro M, Karlsson A, Kagedal A, et al. . Increased il-26 associates with markers of hyperinflammation and tissue damage in patients with acute covid-19. Front Immunol. (2022) 13:1016991. doi: 10.3389/fimmu.2022.1016991</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1016991</ArticleId><ArticleId IdType="pmc">PMC9712219</ArticleId><ArticleId IdType="pubmed">36466824</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund E, Leach S, Axelsson H, Nystrom K, Norder H, Bemark M, et al. . Serum-igg responses to sars-cov-2 after mild and severe covid-19 infection and analysis of igg non-responders. PloS One. (2020) 15:e0241104. doi: 10.1371/journal.pone.0241104</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241104</ArticleId><ArticleId IdType="pmc">PMC7577439</ArticleId><ArticleId IdType="pubmed">33085715</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe covid-19. BMC Infect Dis. (2020) 20:942. doi: 10.1186/s12879-020-05671-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05671-7</ArticleId><ArticleId IdType="pmc">PMC7726600</ArticleId><ArticleId IdType="pubmed">33302893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simren J, Eden A, Andersson LM, Nilsson S, Ashton NJ, et al. . Neurochemical signs of astrocytic and neuronal injury in acute covid-19 normalizes during long-term follow-up. EBioMedicine. (2021) 70:103512. doi: 10.1016/j.ebiom.2021.103512</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren A, Leach S, Axelsson H, Isakson P, Nystrom K, Scharf L, et al. . Plasmablasts in previously immunologically naive covid-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with sars-cov-2 variants and other beta-coronaviruses. Clin Exp Immunol. (2023) 213:173–89. doi: 10.1093/cei/uxad044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxad044</ArticleId><ArticleId IdType="pmc">PMC10361743</ArticleId><ArticleId IdType="pubmed">37071584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Henry BM, Montagnana M, Plebani M. Diagnostic accuracy of the ultrasensitive S-plex sars-cov-2 N electrochemiluminescence immunoassay. Clin Chem Lab Med. (2022) 60:e121–e4. doi: 10.1515/cclm-2022-0155</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2022-0155</ArticleId><ArticleId IdType="pubmed">35285218</ArticleId></ArticleIdList></Reference><Reference><Citation>
(NIH) NIoH . Coronavirus Disease 2019 (Covid-19) Treatment Guidelines (2023). Available online at: https://www.covid19treatmentguidelines.nih.gov/ (Accessed March 17, 2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M, Gelzo M, Sol S, Fedele R, Annunziata A, Calabrese C, et al. . Dysregulation of lipid metabolism and pathological inflammation in patients with covid-19. Sci Rep. (2021) 11:2941. doi: 10.1038/s41598-021-82426-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82426-7</ArticleId><ArticleId IdType="pmc">PMC7859398</ArticleId><ArticleId IdType="pubmed">33536486</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwani M, Yassin A, Al-Zoubi RM, Aboumarzouk OM, Nettleship J, Kelly D, et al. . Sex-based differences in severity and mortality in covid-19. Rev Med Virol. (2021) 31:e2223. doi: 10.1002/rmv.2223</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2223</ArticleId><ArticleId IdType="pmc">PMC8014761</ArticleId><ArticleId IdType="pubmed">33646622</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinelli F, Trevisan C, Noale M, Franchini M, Giacomelli A, Cori L, et al. . Sex- and gender-related differences linked to sars-cov-2 infection among the participants in the web-based epicovid19 survey: the hormonal hypothesis. Maturitas. (2022) 158:61–9. doi: 10.1016/j.maturitas.2021.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2021.11.015</ArticleId><ArticleId IdType="pmc">PMC8642247</ArticleId><ArticleId IdType="pubmed">35241240</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschou SA, Psaltopoulou T, Halvatsiotis P, Raptis A, Vlachopoulos CV, Dimopoulos MA. Gender differences in covid-19. Maturitas. (2022) 161:72–3. doi: 10.1016/j.maturitas.2022.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC8934754</ArticleId><ArticleId IdType="pubmed">35337711</ArticleId></ArticleIdList></Reference><Reference><Citation>Salhi M, Tizaoui K, Louhaichi S, Lahmar O, Hamzaoui K, Hamzaoui A. Il-26 gene variants and protein expression in Tunisian asthmatic patients. Cytokine. (2020) 134:155206. doi: 10.1016/j.cyto.2020.155206</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155206</ArticleId><ArticleId IdType="pubmed">32683104</ArticleId></ArticleIdList></Reference><Reference><Citation>Louhaichi S, Mlika M, Hamdi B, Hamzaoui K, Hamzaoui A. Sputum il-26 is overexpressed in severe asthma and induces proinflammatory cytokine production and th17 cell generation: A case-control study of women. J Asthma Allergy. (2020) 13:95–107. doi: 10.2147/JAA.S229522</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JAA.S229522</ArticleId><ArticleId IdType="pmc">PMC7006858</ArticleId><ArticleId IdType="pubmed">32099415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovach M, Käck U, Che KF, Brundin B, Konradsen J, Lindén A. Systemic il-26 correlates with improved asthma control in children sensitized to dog allergen. Respir Res. (2024) 25(1):163. doi: 10.1186/s12931-024-02773-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-024-02773-7</ArticleId><ArticleId IdType="pmc">PMC11020994</ArticleId><ArticleId IdType="pubmed">38622712</ArticleId></ArticleIdList></Reference><Reference><Citation>Che KF, Tufvesson E, Tengvall S, Lappi-Blanco E, Kaarteenaho R, Levanen B, et al. . The neutrophil-mobilizing cytokine interleukin-26 in the airways of long-term tobacco smokers. Clin Sci (Lond). (2018) 132:959–83. doi: 10.1042/CS20180057</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180057</ArticleId><ArticleId IdType="pmc">PMC6365630</ArticleId><ArticleId IdType="pubmed">29780024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JL, Bain W, Naqvi A, Staines B, Castanha PMS, Yang H, et al. . Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes. Clin Infect Dis. (2022) 74:1525–33. doi: 10.1093/cid/ciab686</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab686</ArticleId><ArticleId IdType="pmc">PMC9070832</ArticleId><ArticleId IdType="pubmed">34374761</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovito R, Bono V, Augello M, Tincati C, Mainoldi F, Beaudoin-Bussieres G, et al. . Association between sars-cov-2 rnaemia and dysregulated immune response in acutely ill hospitalized covid-19 patients. Sci Rep. (2022) 12:19658. doi: 10.1038/s41598-022-23923-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23923-1</ArticleId><ArticleId IdType="pmc">PMC9667450</ArticleId><ArticleId IdType="pubmed">36385627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. . Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (Rnaemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. (2020) 71:1937–42. doi: 10.1093/cid/ciaa449</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Augello M, Bono V, Rovito R, Tincati C, Bianchi S, Taramasso L, et al. . Association between sars-cov-2 rnaemia, skewed T cell responses, inflammation, and severity in hospitalized covid-19 people living with hiv. iScience. (2024) 27:108673. doi: 10.1016/j.isci.2023.108673</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.108673</ArticleId><ArticleId IdType="pmc">PMC10770729</ArticleId><ArticleId IdType="pubmed">38188525</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, et al. . Sars-cov-2 viremia is associated with distinct proteomic pathways and predicts covid-19 outcomes. J Clin Invest. (2021) 131:1–12. doi: 10.1172/JCI148635</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148635</ArticleId><ArticleId IdType="pmc">PMC8245177</ArticleId><ArticleId IdType="pubmed">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: stat1 resolves a paradox. Nat Immunol. (2000) 1:70–6. doi: 10.1038/76940</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/76940</ArticleId><ArticleId IdType="pubmed">10881178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstedt S, Piersiala K, Petro M, Karlsson A, Kagedal A, Kumlien Georen S, et al. . A prolonged innate systemic immune response in covid-19. Sci Rep. (2022) 12:9915. doi: 10.1038/s41598-022-13986-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13986-5</ArticleId><ArticleId IdType="pmc">PMC9200737</ArticleId><ArticleId IdType="pubmed">35705573</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli C, Augusto JF, Dauve J, Adam C, Preisser L, Larochette V, et al. . Il-26 confers proinflammatory properties to extracellular DNA. J Immunol. (2017) 198:3650–61. doi: 10.4049/jimmunol.1600594</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600594</ArticleId><ArticleId IdType="pubmed">28356384</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotter TN, Shuptrine CW, Tsao LC, Marek RD, Acharya C, Wei JP, et al. . Il26, a noncanonical mediator of DNA inflammatory stimulation, promotes tnbc engraftment and progression in association with neutrophils. Cancer Res. (2020) 80:3088–100. doi: 10.1158/0008-5472.CAN-18-3825</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-3825</ArticleId><ArticleId IdType="pmc">PMC7415539</ArticleId><ArticleId IdType="pubmed">32366475</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>